All physical activity matters... to whom?
Revista Brasileira de Ciências do Esporte · 2026 · 48
DOI: 10.1590/rbce.48.e20260101 ↗Kurz gefasst
Fachartikel in der Zeitschrift Revista Brasileira de Ciências do Esporte, 2026. Verfasst von Alexandre Palma und 4 weiteren Autor:innen. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The aim of this essay is to discuss the discourses on the relationship between physical activity (PA), in its different domains, and the reduction in disease prevalence. The benefits of PA for disease prevention have been associated with total energy expenditure. Thus, the practice of all domains of PA would be important for disease prevention. However, unlike what occurs with leisure-time PA, some studies indicate that those who perform the majority of PA in other domains belong to socially vulnerable groups. Therefore, who is the target of leisure-time PA and occupational, domestic, and commuting activities? When it is agreed that people need to add a few minutes of PA per week, regardless of the domain, perhaps a right is being denied to the individual and a process of exploitation of the other's body is being reinforced.
Zitieren
APA
Palma, A., Araújo, M. F. D. S., Paiva, G. B. D., Malacarne, J. A. D., & Rodrigues, P. A. F. (2026). All physical activity matters... to whom?. Revista Brasileira de Ciências do Esporte, 48. https://doi.org/10.1590/rbce.48.e20260101
Vancouver
Palma A, Araújo MFDS, Paiva GBD, Malacarne JAD, Rodrigues PAF. All physical activity matters... to whom?. Revista Brasileira de Ciências do Esporte. 2026;48. doi:10.1590/rbce.48.e20260101
BibTeX
@article{Palma2026,
author = {Palma, Alexandre and Araújo, Mariane Ferreira dos Santos and Paiva, Giovana Barbosa de and Malacarne, José Augusto Dalmonte and Rodrigues, Phillipe Augusto Ferreira},
title = {All physical activity matters... to whom?},
journal = {Revista Brasileira de Ciências do Esporte},
year = {2026},
volume = {48},
doi = {10.1590/rbce.48.e20260101}
}
EUVIMED